Salvage therapy of germ cell tumours
Open Access
- 1 May 1995
- journal article
- editorial
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (5) , 901-903
- https://doi.org/10.1038/bjc.1995.175
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedCancer, 1992
- Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.Journal of Clinical Oncology, 1991
- Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.Journal of Clinical Oncology, 1991
- Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989)Cancer, 1991
- 21-day cycles of oral etoposide in heavily pretreated metastatic germ-cell cancerThe Lancet, 1990
- Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.Journal of Clinical Oncology, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumorsThe American Journal of Medicine, 1985
- Advanced Extragonadal Germ-Cell TumorsAnnals of Internal Medicine, 1982
- VP16-213 as a single agent in advanced testicular tumorsPublished by Elsevier ,1980